10/15/2006 - Lone Star New Markets LP and Lone Star Growth Capital LP Announce Equity Investment In Neuro Resource Group (NRG)
DALLAS (October 15, 2006) – Lone Star New Markets LP and Lone Star Growth Capital LP announced that that they had made and equity investment into Neuro Resource Group (NRG). NRG specializes in the development, design, and manufacture of innovative medical products for injury management, rehabilitation, and pain management. The $3.7 million transaction with NRG represents equity investment in stock, giving Lone Star New Markets (LSNM) and Lone Star Growth Capital (LSCG) a collective 14% ownership in NRG.
Tommy Thompson, President and CEO of NRG brings a wealth of experience in the medical device industry, including five years as Division President for Baxter Healthcare. The other management members have extensive experience in the healthcare industry, high tech electronics, and medical device production.
NRG's focus is on InterX products and therapies. InterX devices are hand-held, battery operated electrical devices that provide neuro-stimulation to tissues for relief of acute and chronic pain and neuropathic pain caused by sports injuries and/or trauma. The InterX therapy is a non-invasive therapy that can be used on patients of all ages. Located in Plano, Texas, the Neuro Resource Group facility qualifies under the New Market Tax Credit Program as it is located in a Community Development Financial Institutions (CDFI) qualifying census tract.
About Lone Star New Markets LP
About Lone Star Growth Capital LP
About Neuro Resource Group (NRG)